Depression screening tools in persons with epilepsy: A systematic review of validated tools

被引:115
|
作者
Gill, Stephanie J. [1 ,2 ]
Lukmanji, Sara [1 ,2 ]
Fiest, Kirsten M. [2 ,3 ,4 ,5 ]
Patten, Scott B. [2 ,3 ,4 ,6 ,7 ]
Wiebe, Samuel [1 ,2 ,3 ,4 ]
Jette, Nathalie [1 ,2 ,3 ,4 ]
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[4] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada
[5] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada
[6] Univ Calgary, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada
[7] Univ Calgary, Dept Psychiat, Calgary, AB, Canada
关键词
Major depressive disorder; Mental health; Comorbidity; Diagnostic accuracy; Measurement; PATIENT HEALTH QUESTIONNAIRE-2; MAJOR DEPRESSION; HOSPITAL ANXIETY; NDDI-E; CHINESE VERSION; SPANISH VERSION; RAPID DETECTION; GERMAN VERSION; RATING-SCALE; PRIMARY-CARE;
D O I
10.1111/epi.13651
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Depression affects approximately 25% of epilepsy patients. However, the optimal tool to screen for depression in epilepsy has not been definitively established. The purpose of this study was to systematically review the literature on the validity of depression-screening tools in epilepsy. Methods: MEDLINE, EMBASE, and PsycINFO were searched until April 4, 2016 with no restriction on dates. Abstract, full-text review and data abstraction were conducted in duplicate. We included studies that evaluated the validity of depression-screening tools and reported measures of diagnostic accuracy (e.g., sensitivity, specificity, and negative and positive predictive values) in epilepsy. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies Version 2. Medians and ranges for estimates of diagnostic accuracy were calculated when appropriate. Results: A total of 16,070 abstracts were screened, and 38 articles met eligibility criteria. Sixteen screening tools were validated in 13 languages. The most commonly validated screening tool was the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) (n=26). The Mini International Neuropsychiatric Interview (MINI) (n=19) was the most common reference standard used. At the most common cutpoint of >15 (n=12 studies), the NDDI-E had a median sensitivity of 80.5% (range 64.0-100.0) and specificity of 86.2 (range 81.0-95.6). Meta-analyses were not possible due to variability in cutpoints assessed, reference standards used, and lack of confidence intervals reported. Significance: A number of studies validated depression screening tools; however, estimates of diagnostic accuracy were inconsistently reported. The validity of scales in practice may have been overestimated, as cutpoints were often selected post hoc based on the study sample. The NDDI-E, which performed well, was the most commonly validated screening tool, is free to the public, and is validated in multiple languages and is easy to administer, although selection of the best tool may vary depending on the setting and available resources.
引用
收藏
页码:695 / 705
页数:11
相关论文
共 50 条
  • [21] The psychometric properties of depression screening tools in primary healthcare settings: A systematic review
    El-Den, Sarira
    Chen, Timothy F.
    Gan, Yuh-Lin
    Wong, Eling
    O'Reilly, Claire L.
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 225 : 503 - 522
  • [22] Depression in persons with epilepsy: A comparative study of different tools in Indian population
    Rashid, Haroon
    Katyal, Jatinder
    Sood, Mamta
    Tripathi, Manjari
    EPILEPSY & BEHAVIOR, 2021, 115
  • [23] Validated Screening Tools for Common Mental Disorders in Low and Middle Income Countries: A Systematic Review
    Ali, Gemma-Claire
    Ryan, Grace
    De Silva, Mary J.
    PLOS ONE, 2016, 11 (06):
  • [24] Systematic review on validated tools measuring women's satisfaction in breast cancer screening programmes
    Deandrea, S.
    Salakari, M.
    Neamtiu, L.
    Freeman, C.
    Uluturk, A.
    Lerda, D.
    Pylkkanen, L.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S89 - S89
  • [25] Validated tools measuring women's satisfaction in breast cancer screening programmes: A systematic review
    Deandrea, Silvia
    Salakari, Minna
    Neamtiu, Luciana
    Uluturk, Asli
    Lerda, Donata
    Pylkkanen, Liisa
    BREAST, 2018, 39 : 33 - 38
  • [26] A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries
    Mughal, Anisa Y.
    Devadas, Jackson
    Ardman, Eric
    Levis, Brooke
    Go, Vivian F.
    Gaynes, Bradley N.
    BMC PSYCHIATRY, 2020, 20 (01)
  • [27] A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries
    Anisa Y. Mughal
    Jackson Devadas
    Eric Ardman
    Brooke Levis
    Vivian F. Go
    Bradley N. Gaynes
    BMC Psychiatry, 20
  • [28] Screening tools for depression in epilepsy - A combination increases detection rate
    Von Oertzen, T. J.
    Thamm, N.
    Schwarz, G.
    Hengsberger, A. M.
    Wagner, J.
    Puttinger, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [29] A SYSTEMATIC REVIEW OF SCREENING TOOLS FOR THE IDENTIFICATION OF SUBJECTS WITH EPILEPSY IN POPULATION-BASED RESEARCH
    Keezer, M. R.
    Wolfson, C.
    EPILEPSIA, 2013, 54 : 274 - 274
  • [30] Validated assessment tools for screen media use: A systematic review
    Perez, Oriana
    Garza, Tatyana
    Hindera, Olivia
    Beltran, Alicia
    Musaad, Salma M.
    Dibbs, Tracey
    Singh, Anu
    Chug, Shria
    Sisson, Amy
    Kumar Vadathya, Anil
    Baranowski, Tom
    O'Connor, Teresia M.
    PLOS ONE, 2023, 18 (04):